Related Experiment Video
Updated: Jun 17, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Bone sporotrichosis: 41 cases from a reference hospital in Rio de Janeiro, Brazil
Vanessa Ramos1, Guis S-M Astacio2, Antonio C F do Valle2
1Pós-Graduação em Medicina Tropical, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Bone sporotrichosis, a rare fungal infection, is increasingly seen in Rio de Janeiro. This study highlights its challenging nature, prolonged treatment, and significant sequelae, especially in immunocompromised individuals.
Area of Science:
- Mycology
- Infectious Diseases
- Osteomyelitis
Background:
- Bone sporotrichosis is a rare clinical manifestation of Sporothrix infection.
- The metropolitan region of Rio de Janeiro is hyperendemic for zoonotic sporotrichosis, with increasing bone involvement.
- Zoonotic sporotrichosis is primarily caused by Sporothrix species, with Sporothrix brasiliensis being a significant agent in Brazil.
Purpose of the Study:
- To describe the clinical characteristics, treatment, and outcomes of bone sporotrichosis.
- To identify risk factors and patterns of bone involvement in a cohort of patients.
- To analyze the efficacy of treatment regimens and associated sequelae.
Main Methods:
- Retrospective cohort study of 41 bone sporotrichosis cases diagnosed between 1999 and 2016.
- Inclusion criteria involved fungal culture isolation from clinical specimens with radiographic or histopathological evidence of bone involvement.
- Molecular identification of the causative agent was performed when feasible.
Main Results:
- The majority of patients (58.5%) were male, with a median age of 43 years.
- Immunosuppressive conditions, particularly HIV coinfection (51.2%), were present in 68.3% of patients.
- Multifocal bone involvement (61%) was common, with hands (58.5%), feet (41.5%), and tibia (26.8%) being most affected. Sporothrix brasiliensis was identified in 22% of cases.
- Treatment with Amphotericin B followed by itraconazole yielded a 53.7% cure rate, significantly lower in immunocompromised patients (39.3%) compared to immunocompetent ones (84.6%).
- Sequelae included amputations (7.3%) and ankylosis (4.9%), with a 22% mortality rate.
Conclusions:
- Bone sporotrichosis is a chronic and complex infection requiring prolonged treatment.
- Outcomes are often poor, with significant sequelae and mortality, particularly in immunocompromised individuals.
- The increasing incidence and challenging management underscore the need for heightened awareness and effective therapeutic strategies.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Bacterial Phylum Spirochaetes
Rocky Mountain Spotted Fever
Leishmaniasis

